Form POS EX - Post-effective amendment adding exhibits to registration statement [Rule 462(d)]:
SEC Accession No. 0001193125-22-120471
Filing Date
2022-04-26
Accepted
2022-04-26 17:13:01
Documents
5
Effectiveness Date
2022-04-26

Document Format Files

Seq Description Document Type Size
1 BLACKROCK HEALTH SCIENCES TRUST d269284dposex.htm POS EX 114901
2 FORM OF DISTRIBUTION AGREEMENT d269284dex99h1.htm EX-99.(H)(1) 62549
3 FORM OF SUB-PLACEMENT AGENT AGREEMENT d269284dex99h2.htm EX-99.(H)(2) 68601
4 OPINION AND CONSENT OF COUNSEL TO THE REGISTRANT d269284dex99l2.htm EX-99.(L)(2) 16171
5 CALCULATION OF FILING FEE TABLES (FINAL PROSPECTUS DATED APRIL 26, 2022) d269284dex99s3.htm EX-99.(S)(3) 1939
  Complete submission text file 0001193125-22-120471.txt   265048
Mailing Address 100 BELLEVUE PARKWAY WILMINGTON DE 19809
Business Address 100 BELLEVUE PARKWAY WILMINGTON DE 19809 (888) 825-2257
BlackRock Health Sciences Trust (Filer) CIK: 0001314966 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: POS EX | Act: 33 | File No.: 333-263527 | Film No.: 22855324